ACM
Asymmetry Capital Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $8.28M | Buy |
716,709
+62,733
| +10% | +$725K | 4.39% | 11 |
|
|
2021
Q3 | $6.25M | Buy |
653,976
+354,692
| +119% | +$3.39M | 3.75% | 14 |
|
|
2021
Q2 | $2.89M | Buy |
+299,284
| New | +$2.89M | 1.98% | 19 |
|
|
2020
Q3 | – | Sell |
-234,753
| Closed | -$3.54M | – | 40 |
|
|
2020
Q2 | $3.54M | Sell |
234,753
-83,399
| -26% | -$1.26M | 2.71% | 17 |
|
|
2020
Q1 | $2.94M | Buy |
318,152
+219,434
| +222% | +$2.03M | 3.22% | 13 |
|
|
2019
Q4 | $962K | Buy |
+98,718
| New | +$962K | 1.72% | 27 |
|
|
2019
Q1 | – | Sell |
-97,294
| Closed | -$932K | – | 30 |
|
|
2018
Q4 | $932K | Sell |
97,294
-260,897
| -73% | -$2.5M | 2.57% | 14 |
|
|
2018
Q3 | $4.33M | Buy |
358,191
+226,031
| +171% | +$2.73M | 4% | 7 |
|
|
2018
Q2 | $2.06M | Sell |
132,160
-62,585
| -32% | -$977K | 2.03% | 20 |
|
|
2018
Q1 | $2.93M | Sell |
194,745
-18,668
| -9% | -$281K | 3.66% | 10 |
|
|
2017
Q4 | $3.07M | Buy |
213,413
+354
| +0.2% | +$5.09K | 4.17% | 9 |
|
|
2017
Q3 | $3.21M | Sell |
213,059
-188,850
| -47% | -$2.85M | 3.73% | 10 |
|
|
2017
Q2 | $4.05M | Sell |
401,909
-232,956
| -37% | -$2.35M | 4.8% | 10 |
|
|
2017
Q1 | $4.53M | Sell |
634,865
-121,731
| -16% | -$868K | 6.31% | 7 |
|
|
2016
Q4 | $3.76M | Buy |
756,596
+138,279
| +22% | +$687K | 6.99% | 6 |
|
|
2016
Q3 | $4.58M | Buy |
618,317
+388,691
| +169% | +$2.88M | 7.96% | 4 |
|
|
2016
Q2 | $1.25M | Sell |
229,626
-103,887
| -31% | -$567K | 2.3% | 18 |
|
|
2016
Q1 | $2.82M | Buy |
333,513
+138,307
| +71% | +$1.17M | 7.35% | 4 |
|
|
2015
Q4 | $1.89M | Sell |
195,206
-37,751
| -16% | -$366K | 2.86% | 15 |
|
|
2015
Q3 | $3.26M | Buy |
+232,957
| New | +$3.26M | 7.26% | 4 |
|